Trial Studying Chemotherapy in Nigerian Women With Triple Negative Breast Cancer

NCT06291064 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

85

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Cyclophosphamide
DRUG: Epirubicin
DRUG: Docetaxel
DRUG: Carboplatin
PROCEDURE: Breast Surgery
DRUG: Capecitabine

Sponsor

University of Chicago